Dosage ; Intravenous, 1.5 to 5mL per varix, up to a maximum
dose of 20mL per treatment session.
Combinations ; - see below
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Ethanolamine | Martindale Pharmaceuticals | Laborex Kenya Eurapharma Ltd | 5% | 50ml | Injection | per vial | KES 3,950.00 |
| Ethanolamine More info | |
|---|---|
| Mode Of Action | Sclerosing agent. |
| Drug Indication | Treatment of bleeding esophageal varices, treatment of cystic lesions (including testicular hydroceles, spermatoceles, and renal cysts). |
| Contra-Indications | Patients allergic to oleic acid, or morrhuate sodium may be allergic to ethanolamine oleate; pregnancy. |
| Side Effects | Portal gastropathy may develop following endoscopic injection sclerotherapy of esophageal varices; esophageal stricture; pneumonia, allergic reactions; CNS infections; disseminated intravascular coagulation; esophageal perforation; aspiration pneumonia; portal vein thrombosis; renal failure, acute; spinal cord paralysis; chest pain; dysphagia; fever; abnormal chest x-rays, including pulmonary infiltrates and pleural effusions; esophageal ulceration. |
| Dosage | Intravenous, 1.5 to 5mL per varix, up to a maximum dose of 20mL per treatment session. |
| Drug Category | DRUGS ACTI NG ON THE CARDIO-VASCULAR SYSTEM |